Improved Survival for Patients With Follicular Lymphoma
- 1 August 2005
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (22) , 4830-4831
- https://doi.org/10.1200/jco.2005.03.911
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Improved Survival of Follicular Lymphoma Patients in the United StatesJournal of Clinical Oncology, 2005
- Meta-Analysis to Evaluate the Role of Interferon in Follicular LymphomaJournal of Clinical Oncology, 2005
- Microarray Guided Flow Cytometry: CD44 and CD27 Are Extremely Powerful Discriminators of ALL Subtypes.Blood, 2004
- Stage I and II Follicular Non-Hodgkin’s Lymphoma: Long-Term Follow-Up of No Initial TherapyJournal of Clinical Oncology, 2004
- High-Dose Therapy Improves Progression-Free Survival and Survival in Relapsed Follicular Non-Hodgkin’s Lymphoma: Results From the Randomized European CUP TrialJournal of Clinical Oncology, 2003
- Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trialThe Lancet, 2003
- Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.Journal of Clinical Oncology, 1997
- Non-hodgkin's lymphomas iv. clinicopathologic correlation in 405 casesCancer, 1973
- Clinical Trials of p-(Di-2-chloroethylamine)-phenylbutyric Acid (CB 1348) in Malignant LymphomaBMJ, 1955